IA
TNGX icon

IFP Advisors’s Tango Therapeutics TNGX Stock Holding History

IFP Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57K Sell
210
-23
-10% -$569 ﹤0.01% 3623
2026
Q1 		$4.87K Hold
233
– – ﹤0.01% 3541
2025
Q4 		$2.06K Hold
233
– – ﹤0.01% 3821
2025
Q3 		$1.96K Hold
233
– – ﹤0.01% 3703
2025
Q2 		$1.19K Buy
+233
New +$576 ﹤0.01% 4157
2024
Q4 		– Hold
0
– – – 4164

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

IFP Advisors's TNGX Position: Q2 2026 in Review

IFP Advisors reduced its Tango Therapeutics (TNGX) stake by 9.9% in Q2 2026, selling an estimated $569 and leaving 210 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3623.

IFP Advisors first reported a position in TNGX in Q2 2025 and has held it in 5 quarters since. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • IFP Advisors held 210 shares of Tango Therapeutics worth $6.57K as of Q2 2026.
  • IFP Advisors sold 23 Tango Therapeutics shares in Q2 2026, an estimated $569.
  • Tango Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3623 holding.
  • IFP Advisors first reported a position in Tango Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.